ADSUNIB(Sunitinib Malate )
Therapeutic class: Kinase Inhibitors
- Gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
- Advanced renal cell carcinoma (RCC)
- Progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in patients with unresectable locally advanced or metastatic disease.
12.5mg & 25mg & 50mg Capsules
12.5mg:-
A bottle of 28 Capsules25 mg:-
A bottle of 28 Capsules50 mg:-
A bottle of 28 Capsules- 20°C to 25°C (68°F to 77°F), Shelf Life: 2 Years
- As directed by physician
